Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for m root_references_citation in Reference Text / Citation (approximate match)

Showing 361 - 370 of 1135 results

First page
Previous page
Next page
Next page

OGT-719

OMZ81A5KDU

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

SAR-7226

9GAQ074U93

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

CKD-712

PW8215U0ZU

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Heme oxygenase 1

ETHYL 1-METHYLETHYL (5RS)-5-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-5-OXO-2,4,6,8-TETRAOXA-5-.LAMBDA.5-PHOSPHANONANEDIOATE

QB3AC2AM3R

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

N-CAFFEOYLALANINE

C7G6G5T5J7

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

N-Caffeoyltryptophan

D9G5AEW898

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

N-(E)-CAFFEOYL-L-TYROSINE

C6KYU23R4U

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

N-CAFFEOYL-.BETA.-ALANINE

8ZM79N446A

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

N-DEHYDROXYZILEUTON

XT4JU9PDN5

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

TAK-779 CATION

RN3X97C29H

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

C-C chemokine receptor type 5

C-C chemokine receptor type 2

Human immunodeficiency virus 1

C-C chemokine receptor type 5

Conditions:

Focal cerebral ischemia

TAK-779 is a selective antagonist of CCR5 receptor, which was initially developed by Takeda for the treatment of HIV infection. However, the development was terminated due to poor oral bioavailability. Also, TAK-779 demonstrated the ability to protect the brain against focal cerebral ischemia in mice.

Structure of OGT-719

ABSOLUTE

Structure of SAR-7226

ABSOLUTE

Structure of CKD-712

ABSOLUTE

Structure of ETHYL 1-METHYLETHYL (5RS)-5-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-5-OXO-2,4,6,8-TETRAOXA-5-.LAMBDA.5-PHOSPHANONANEDIOATE

ABSOLUTE

ETHYL 1-METHYLETHYL (5RS)-5-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-5-OXO-2,4,6,8-TETRAOXA-5-.LAMBDA.5-PHOSPHANONANEDIOATE

Structure of N-CAFFEOYLALANINE

ABSOLUTE

N-CAFFEOYLALANINE

Structure of N-Caffeoyltryptophan

ABSOLUTE

N-Caffeoyltryptophan

Structure of N-(E)-CAFFEOYL-L-TYROSINE

ABSOLUTE

N-(E)-CAFFEOYL-L-TYROSINE

Structure of N-CAFFEOYL-.BETA.-ALANINE

ACHIRAL

N-CAFFEOYL-.BETA.-ALANINE

Structure of N-DEHYDROXYZILEUTON

RACEMIC

N-DEHYDROXYZILEUTON

Structure of TAK-779 CATION

ACHIRAL

Showing 361 - 370 of 1135 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1